Literature DB >> 16096606

Myasthenia gravis: myasthenia vs. cholinergic crisis.

Kelly A Hetherington1, Joseph D Losek.   

Abstract

A serious complication of myasthenia gravis is respiratory failure. This may be secondary to an exacerbation of myasthenia (myasthenia crisis) or to treatment with excess doses of a cholinesterase inhibitor (cholinergic crisis). Managing respiratory failure and differentiating a myasthenia from a cholinergic crisis is reviewed. Due to the unpredictable development of respiratory failure, hospitalization is recommended for most patients with exacerbations or complications of myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16096606     DOI: 10.1097/01.pec.0000173353.76142.81

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  5 in total

1.  Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality.

Authors:  Einor Ben Assayag; Shani Shenhar-Tsarfaty; Keren Ofek; Lilach Soreq; Irena Bova; Ludmila Shopin; Ronan M G Berg; Shlomo Berliner; Itzhak Shapira; Natan M Bornstein; Hermona Soreq
Journal:  Mol Med       Date:  2010-04-14       Impact factor: 6.354

2.  Cholinergic Crisis Caused by Cholinesterase Inhibitors: a Retrospective Nationwide Database Study.

Authors:  Hiroyuki Ohbe; Taisuke Jo; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  J Med Toxicol       Date:  2018-06-15

3.  Lambert-Eaton myasthenic syndrome as a cause of persistent neuromuscular weakness after a mediastinoscopic biopsy -A case report-.

Authors:  Cheol Jin Lee; Se Hun Lim; Chee Mahn Shin; Young Jae Kim; Young Kyun Choe; Soon Ho Cheong; Kun Moo Lee; Jeong Han Lee; Young Hwan Kim; Kwang Rae Cho; Sang Eun Lee; Jong Suk Bae
Journal:  Korean J Anesthesiol       Date:  2010-07-21

4.  Anti-MuSK-Positive Myasthenic Crisis in a 7-Year-Old Female.

Authors:  Harrison J Matthews; Apisadaporn Thambundit; Brandon R Allen
Journal:  Case Rep Emerg Med       Date:  2017-04-30

Review 5.  Application of In Vitro Metabolism Activation in High-Throughput Screening.

Authors:  Masato Ooka; Caitlin Lynch; Menghang Xia
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.